Balyasny Asset Management
KURA icon

Balyasny Asset Management’s Kura Oncology KURA Stock Holding History

Balyasny Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-679,500
Closed -$6.01M – 3338
2025
Q3 		$6.01M Buy
+679,500
New +$4.84M 0.01% 1287

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Balyasny Asset Management's KURA Position: Q4 2025 in Review

Balyasny Asset Management sold out of Kura Oncology (KURA) in Q4 2025, closing a stake of 86,798 shares — an estimated $768K sold.

Balyasny Asset Management first reported a position in KURA in Q2 2022 and held it in 10 quarters. The position peaked at $28.5M in Q4 2022. 215 funds tracked by Wall St. Rank hold KURA as of Q4 2025.

  • Balyasny Asset Management reported no remaining Kura Oncology position as of Q4 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 86,798 Kura Oncology shares in Q4 2025, an estimated $768K.
  • Balyasny Asset Management first reported a position in Kura Oncology in Q2 2022 and held it in 10 quarters.
  • Balyasny Asset Management's Kura Oncology position peaked at $28.5M in Q4 2022.
  • 215 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.